The sustainability of bioprocessing depends on many decisions and technologies. Sustainability and other factors must be in ...

Read the Market Summary Here:- https://reportocean.com/industry-verticals/sample-request?report_id=bw8547 ...

Celonic Group, a leading Swiss-based contract development and manufacturing organisation (CDMO), has integrated Merck’s Breez™ micro-bioreactor platform into its process development workflow.

Repligen (RGEN) and 908 Devices (MASS) announced that Repligen has purchased 908 Devices’ desktop portfolio of four devices for bioprocessing ...

The Breez 2 mL micro-bioreactor platform is a fully automated, functionally closed, and continuous perfusion cell culture ...

Repligen Corporation has acquired 908 Devices' desktop portfolio, which includes four analytical devices for bioprocessing applications, for $70 million in cash. This acquisition enhances Repligen ...

WALTHAM, Mass. and BOSTON, March 04, 2025 (GLOBE NEWSWIRE) -- Repligen Corporation (Nasdaq: RGEN), a life sciences company focused on bioprocessing technology leadership, and 908 Devices Inc ...

Celonic Group, a Swiss-Based Quality CDMO, is integrating Merck’s Breez micro-bioreactor platform into its process ...

After Repligen (RGEN) announced that it has purchased 908 Devices’ (MASS) desktop portfolio of four devices for bioprocessing process ...

Repligen Corporation (NASDAQ:RGEN) purchased 908 Devices Inc.’s (NASDAQ:MASS) desktop portfolio of four devices for ...